PubRank

Pietro Scalfaro

Author PubWeight™ 14.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus. Hepatology 2008 2.24
2 The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology 2006 1.99
3 Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo. Hepatology 2007 1.95
4 The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients. Hepatology 2009 1.75
5 Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother 2008 1.46
6 Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells. J Biol Chem 2005 1.45
7 Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2007 1.18
8 Successful management of severe respiratory failure combining heliox with noninvasive high-frequency percussive ventilation. Crit Care Med 2002 0.86
9 Prevalence of nosocomial infections in Swiss children's hospitals. Infect Control Hosp Epidemiol 2004 0.81
10 Feasibility of non-invasive pressure support ventilation in infants with respiratory failure after extubation: a pilot study. Intensive Care Med 2009 0.80
11 Measuring end-expiratory lung volume and pulmonary mechanics to detect early lung function impairment in rabbits. Respir Physiol Neurobiol 2005 0.78
12 [Heliox in pediatrics]. Rev Med Suisse Romande 2002 0.75